Letter

Imaging peripheral disease

Gadolinium contrast may be risky in kidney disease

BMJ 2007; 334 doi: 10.1136/bmj.39254.924641.1F (Published 28 June 2007)
Cite this as: BMJ 2007;334:1335.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter C Thomson, research fellow in nephrology1,
  2. Tara A Collidge, specialist registrar1,
  3. Patrick B Mark, specialist registrar2,
  4. Jamie P Traynor, specialist registrar2
  1. 1Renal Unit, Glasgow Royal Infirmary, Glasgow G4 0SF
  2. 2Renal Unit, Western Infirmary, Glasgow G11 6PE
  1. peter.thomson{at}northglasgow.scot.nhs.uk

    Collins et al and the accompanying editorial conclude that contrast enhanced magnetic resonance angiography (MRA) is a viable alternative to conventional contrast angiography for assessing patients with peripheral arterial disease before treatment.1 2 The authors found an adverse event rate of up to 10% associated with contrast …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular